CVS Health
CVS
2,329 hedge funds and large institutions have $98.9B invested in CVS Health in 2022 Q3 according to their latest regulatory filings, with 143 funds opening new positions, 1,027 increasing their positions, 913 reducing their positions, and 89 closing their positions.
61% more first-time investments, than exits
New positions opened: 143 | Existing positions closed: 89
38% more call options, than puts
Call options by funds: $1.57B | Put options by funds: $1.14B
26% more capital inflows, than outflows
Capital inflows: $3.65B | Capital outflows: $2.88B
23% more funds holding in top 10
Funds holding in top 10: 139 → 171 (+32)
12% more repeat investments, than reductions
Existing positions increased: 1,027 | Existing positions reduced: 913
1% more funds holding
Funds holding: 2,311 → 2,329 (+18)
0.43% more ownership
Funds ownership: 78.54% → 78.97% (+0.43%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Amundi
Paris,
France
|
+$226M |
| 2 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$205M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$204M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$171M |
| 5 |
Man Group
London,
United Kingdom
|
+$142M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Veritas Asset Management
London,
United Kingdom
|
-$162M |
| 2 |
Nordea Investment Management
Stockholm,
Sweden
|
-$97.3M |
| 3 |
Two Sigma Investments
New York
|
-$96.4M |
| 4 |
INTECH Investment Management
West Palm Beach,
Florida
|
-$94.6M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$89.9M |
CVS Hedge Fund Activity: Q3 2022 in Review
2,329 of the 5,832 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2022, worth a combined $98.9B — up 3.5% from $95.6B a quarter earlier.
Buyers outnumbered sellers: 143 funds opened new CVS positions and 89 closed out — a net gain of 54 holders — while 1,027 added to existing stakes and 913 trimmed.
The largest buyer was Amundi, adding an estimated $226M. The largest seller was Veritas Asset Management, cutting an estimated $162M.
- 2,329 institutional investors held CVS Health (CVS) as of Q3 2022, up from 2,311 in Q2 2022.
- Funds reported $98.9B of CVS Health stock for Q3 2022, up 3.5% quarter-over-quarter.
- 143 funds opened new CVS Health positions in Q3 2022 and 89 closed out, a net change of +54 holders.
- The largest CVS Health buyer in Q3 2022 was Amundi, an estimated $226M added.
- The largest CVS Health seller in Q3 2022 was Veritas Asset Management, an estimated $162M sold.
Based on aggregated 13F filings for Q3 2022.